(S)-Veliflapon structure
|
Common Name | (S)-Veliflapon | ||
|---|---|---|---|---|
| CAS Number | 128253-32-7 | Molecular Weight | 361.43 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C23H23NO3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of (S)-Veliflapon(S)-Veliflapon ((S)-BAY X 1005; (S)-DG-031) is an orally active inhibitor of leukotriene biosynthesis and 5-lipoxygenase activating protein (FLAP). (S)-Veliflapon inhibits the formation of leukotriene B4 (LTB4) in rat, mouse and human leukocytes with IC50 values of 0.026 µM, 0.039 µM and 0.22 µM respectively. (S)-Veliflapon showes enantioselectivity in human whole blood[1][2][3]. |
| Name | (S)-Veliflapon |
|---|
| Description | (S)-Veliflapon ((S)-BAY X 1005; (S)-DG-031) is an orally active inhibitor of leukotriene biosynthesis and 5-lipoxygenase activating protein (FLAP). (S)-Veliflapon inhibits the formation of leukotriene B4 (LTB4) in rat, mouse and human leukocytes with IC50 values of 0.026 µM, 0.039 µM and 0.22 µM respectively. (S)-Veliflapon showes enantioselectivity in human whole blood[1][2][3]. |
|---|---|
| Related Catalog | |
| In Vitro | (S)-Veliflapon 以剂量依赖性方式减少了人全血中白三烯 B4 (LTB4) 的合成[1]。 |
| References |
| Molecular Formula | C23H23NO3 |
|---|---|
| Molecular Weight | 361.43 |